Last Price
0.856
Today's Change
-0.024 (2.72%)
Day's Change
0.821 - 0.91
Trading Volume
708,034
Market Cap
4 Million
Shares Outstanding
5 Million
Avg Volume
2,583,042
Avg Price (50 Days)
1.06
Avg Price (200 Days)
1.18
PE Ratio
-0.30
EPS
-2.84
Earnings Announcement
13-Nov-2024
Previous Close
0.88
Open
0.91
Day's Range
0.8208 - 0.91
Year Range
0.61 - 4.32
Trading Volume
708,034
1 Day Change
-2.72%
5 Day Change
-11.74%
1 Month Change
7.01%
3 Month Change
-34.65%
6 Month Change
-32.06%
Ytd Change
-69.42%
1 Year Change
-77.65%
3 Year Change
-98.76%
5 Year Change
-99.03%
10 Year Change
-99.03%
Max Change
-99.03%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.